Kewaunee Scientific Corp (KEQU) — Titan Protect Analysis

KEQU

Kewaunee Scientific Corp

Consumer Cyclical · ·

$37.41

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$118M

Total market value of the company

Trailing P/E

11.07

Reasonably valued

Forward P/E

19.07

Based on estimated future earnings — lower means cheaper

Rev Growth

+3.3%

Year-over-year revenue change

Profit Margin

3.9%

How much profit the company keeps from each dollar of revenue

ROE

17.4%

Return on equity — how efficiently it uses shareholder money

Analyst Target

N/A

Recommendation

NONE

Consensus view from ? analysts covering this stock

About Kewaunee Scientific Corp

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other g

https://www.kewaunee.com

Country: United States Employees: 1,239 Industry: Furnishings, Fixtures & Appliances

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.257

Positive but modest risk-adjusted returns

Kelly Fraction

0.0117

Marginal edge — very small allocation suggested

Calmar Ratio

-0.050

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-2.8%

Historical annualised return based on price data

Max Drawdown

-55.4%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.69

Less volatile than the market — more defensive

52W High

$60.89

39% below the year high

52W Low

$33.70

11% above the year low

Avg Volume

4,457

Average daily shares traded — higher means easier to buy and sell

Short Ratio

20.3

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$3.72

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

81.82

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

28.9%

Revenue left after cost of goods — higher means pricing power

Operating Margin

3.7%

Profit from core operations before interest and tax

Free Cash Flow

$15M

Positive — the business generates more cash than it spends

Revenue (TTM)

$288M

Total revenue over the last 12 months

Net Income

$11M

Profitable — the bottom line is positive

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go